Future-proofing the pharmacy profession in a hypercompetitive market

Research in Social and Administrative Pharmacy

Volumn 10, Issue 2, 2014, Pages 459-468

  Singleton, Judith A ^a,b   Nissen, Lisa M ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Community pharmacy; Differentiation; Hypercompetition; Hypercompetitive pharmacy market; Pharmacy; Professional services; Strategy

Indexed keywords

AUSTRALIA; COMMERCIAL PHENOMENA; DIFFERENTIATION; HUMAN; HUMAN RELATION; HYPERCOMPETITION; HYPERCOMPETITIVE PHARMACY MARKET; NOTE; ORGANIZATION; PHARMACIST; PHARMACY; PROFESSIONAL SERVICES; PROFESSIONAL STANDARD; STRATEGY;

COMMUNITY PHARMACY; DIFFERENTIATION; HYPERCOMPETITION; HYPERCOMPETITIVE PHARMACY MARKET; PHARMACY; PROFESSIONAL SERVICES; STRATEGY;

AUSTRALIA; COMMUNITY PHARMACY SERVICES; HUMANS; ORGANIZATIONAL INNOVATION; PHARMACIES; PHARMACISTS; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; SMALL BUSINESS;

EID: 84896717041     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2013.05.010     Document Type: Note

References (59)

1. Benrimoj S.I., Frommer M.S. Community pharmacy in Australia. Aust Health Rev 2004, 28:238-246.
2. D'Aveni R. How to escape the differentiation proliferation trap. Strat Leader 2010, 38:244-249.
3. Australian Government: Department of Human Services Medicare 2013, Australian Government, Canberra, Available from:, [cited April 14, 2013]. http://www.medicareaustralia.gov.au/provider/medicare/index.jsp.
4. Johar M., Savage E. Do private patients have shorter waiting times for elective surgery? Evidence from New South Wales public hospitals. Econ Pap 2010, 29:128-142.
5. Australian Government - Department of Health and Ageing Pharmaceutical Benefits Scheme (PBS) 2013, Commonwealth of Australia, Canberra, Available from:, [cited April 16, 2013]. http://www.pbs.gov.au/pbs/home.
6. Australian Government - Department of Health and Ageing Price Disclosure (EAPD) 2010, Commonwealth of Australia, Canberra, Available from:, [cited April 16, 2013]. http://www.pbs.gov.au/info/industry/pricing/eapd.
7. Thurecht N. Generics part one: a force for change. Aust J Pharm 2012, 93:46-48.
8. Thurecht N. Generics part two: diminishing time and opportunity. Aust J Pharm 2012, 93:52-55.
9. Roberts A.S., Benrimoj S.I., Chen T.F., Williams K.A., Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother 2008, 42:861-868.
10. The Pharmacy Guild of Australia Community Pharmacy Agreements 2000, Available from:, [cited April 22, 2013]. http://www.guild.org.au/The_Guild/tab-TheGuild/Community_Pharmacy_Agreements/Community+Pharmacy+Agreement.page.
11. The Pharmacy Guild of Australia. About the Guild.Canberra: The Pharmacy Guild of Australia. Available from: [cited April 16, 2013]. http://www.guild.org.au/The_Guild/tab-TheGuild/About_The_Guild/About+the+Guild.page.
12. Australian Government Fair Work Act 2009 Amendments 2012, Office of Parliamentary Counsel, Canberra.
13. Australian Government - Department of Health and Ageing Pharmacy and Government Arrangements - Fifth Community Pharmacy Agreement 2012, Commonwealth of Australia, Canberra, Available from:, [cited April 16, 2013]. http://www.health.gov.au/internet/main/publishing.nsf/Content/fifth-community-pharmacy-agreement.
14. Australian Government The Fifth Community Pharmacy Agreement Between the Commonwealth of Australia and the Pharmacy Guild of Australia 2010, The Commonwealth of Australia, Canberra, p. 1-36.
15. The Pharmacy Guild of Australia Guildcare Programs 2011, The Pharmacy Guild of Australia, Canberra, Available from:, [cited April 16, 2013]. http://www.guildlink.com.au/patient-care/about-us/guildcare-programs/.
16. Hitt M.A., Ireland R.D., Hoskisson R.E. Strategic Management: Competitiveness and Globalization 2011, Thomson/South-Western, Mason, OH, USA. Concepts 9th ed.
17. Foster S. Hole-in-Wall' Chemists Fill Market Gap 2012, Courier-Mail, Available from:, [cited September 24, 2012]. http://www.couriermail.com.au/business/your-business/hole-in-wall-chemists-fill-market-gap/story-fn7ve1pb-1226480073546.
18. APHS Introducing APHS 2013, APHS, Brisbane, Available from:, [cited April 16, 2013]. http://www.aphs.com.au/index.php/about/.
19. White L., Klinner C. Service quality in community pharmacy: an exploration of determinants. Res Soc Adm Pharm 2012, 8:122-132.
20. D'Aveni R.A. Hypercompetition: Managing the Dynamics of Strategic Manoeuvring 1994, Free Press, New York.
21. D'Aveni R.A., Dagnino G.B., Smith K.G. The age of temporary advantage. Strateg Manag J 2010, 31:1371-1385.
22. Hitt M.A., Ireland R.D., Hoskisson R.E. Strategic Management - Competiveness and Globalisation 2011, South-Western Cengage Learning, Mason, OH, USA. 9th ed.
23. Merriam-Webster 2013, Available from:, [cited January 18, 2013]. http://www.merriam-webster.com/dictionary/commoditize.
24. Thomas J. Channel 7 Pharmacy Wars: Massive Savings 2010, Today Tonight, Sydney, 5 mins.
25. A Current Affair Pharmacy Price Wars: Channel 9 2011, Available from:, [cited April 16, 2013]. http://aca.ninemsn.com.au/article.aspx%3fid%3d8253555.
26. Urban R. Chemmart Takes the Lead in Pharmacy Wars 2012, The Australian, Available from:, [cited April 16, 2013. http://www.theaustralian.com.au/business/companies/chemmart-takes-the-lead-in-pharmacy-wars/story-fn91v9q3-1226530804258.
27. KordaMentha Retail Pharmacy - Ready to Take its Medicine? 2011.
28. The Pharmacy Guild of Australia Guild Digest 2012: A Survey of Independent Pharmacy Operations in Australia Financial Year 2010-11 2012.
29. Nandakumar M.K., Ghobadian M., O'Regan N. Business-level strategy and performance: the moderating effects of environment and structure. Manag Decis 2010, 48:907-939.
30. Berbatis C.G., Sunderland V.B., Joyce A., Bulsara M., Mills C. Enhanced pharmacy services, barriers and facilitators in Australia's community pharmacies: Australia's National Pharmacy Database Project. Int J Pharm Pract 2007, 15:185-191.
31. Larson R.A. Patients' willingness to pay for pharmaceutical care. J Am Pharm Assoc 2000, 40:618-624.
32. Albrecht L.C., Roberts A.S., Benrimoj C.S.I., Williams K.A., Chen T.F., Aslani P. Cognitive pharmaceutical services: financial facilitators. Aust Pharmacist 2006, 25:455-466.
33. Peterson G., Tenni P., Jackson S., et al. Documenting Clinical Interventions in Community Pharmacy: PROMISe III 2009, Pharmacy Guild of Australia, 008-09.
34. Christensen D.B., Neil N., Fassett W.E., Smith D.H., Holmes G., Stergachis A. Frequency and characteristics of cognitive services provided in response to a financial incentive. J Am Pharm Assoc 2000, 40:609-617.
35. Benrimoj S.I., Langford J.H., Berry G., et al. Economic impact of increased clinical intervention rates in community pharmacy: a randomised trial of the effect of education and professional allowance. Pharmacoeconomics 2000, 18:459-468.
36. Chui M.A., Mott D.A., Maxwell L. A qualitative assessment of a community pharmacy cognitive pharmaceutical services program, using a work system approach. Res Soc Adm Pharm 2012, 8:206-216.
37. Barner J.C., Branvold A. Patients' willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultations. Res Soc Adm Pharm 2005, 1:77-100.
38. Payne K., Elliott R. Using discrete choice experiments to value preferences for pharmacy services. Int J Pharm Pract 2005, 13:9-20.
39. Painter J.T., Blumenschein K. PHP61 willingness to pay for pharmacy services: a review. Value Health 2010, 13:A92-A93.
40. Blumenschein K., Johannesson M. Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature. Clin Ther 1999, 21:1402-1417.
41. Gore P.R., Madhavan S. Consumers' preference and willingness to pay for pharmacist counselling for non-prescription medicines. J Clin Pharm Ther 1994, 19:17-25.
42. Einarson T., Bootman J., McGhan W., Larson L., Gardner M., Donohue M. Establishment and evaluation of a serum cholesterol monitoring service in a community pharmacy. Ann Pharmacother 1988, 22:45-48.
43. Reutzel T., Furmaga E. Willingness to pay for pharmacist services in a veterans administration hospital. J Res Pharm Econ 1993, 5:89-114.
44. Suh D.C. Consumers' willingness to pay for pharmacy services that reduce risk of medication-related problems. J Am Pharm Assoc (Wash) 2000, 40:818-827.
45. Naik-Panvelkar P., Armour C., Rose J., Saini B. Patients' value of asthma services in Australian pharmacies: the way ahead for asthma care. J Asthma 2012, 49:310-316.
46. Mansell K., Perepelkin J. Patient awareness of specialized diabetes services provided in community pharmacies. Res Soc Adm Pharm 2011, 7:396-405.
47. Hanna A., White L., Yanamandram V. Patients' willingness to pay for diabetes disease state management services in Australian community pharmacies. Int J Pharm Healthc Market 2010, 4:339-354.
48. Taylor S.J., Armour C.L. Acceptability of willingness to pay techniques to consumers. Health Expect 2002, 5:341-356.
49. Mutnick A.H., Sterba K.J., Peroutka J.A., Sloan N.E., Beltz E.A., Sorenson M.K. Cost savings and avoidance from clinical interventions. Am J Health Syst Pharm 1997, 54:392-396.
50. McMullin S.T., Hennenfent J.A., Ritchie D.J., et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 1999, 159:2306-2309.
51. de Rijdt T., Willems L., Simoens S. Economic effectsof clinical pharmacy interventions: a literature review. Am J Health Syst Pharm 2008, 65:1161-1172.
52. Marino J., Caballero J., Llosent M., Hinkes R. Differences in pharmacy interventions at a psychiatric hospital: comparison of staff pharmacists, pharmacy faculty, and student pharmacists. Hosp Pharm 2010, 45:314-319.
53. Krass I., Armour C.L., Mitchell B., et al. The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med 2007, 24:677-683.
54. McGee J.E., Love L.G., Festervand T.A. Competitive advantage and the independent retail pharmacy: the role of distinctive competencies. J Pharm Mark Manage 2000, 13:31-46.
55. Wiggins R.R., Ruefli T.W. Schumpeter's ghost: is hypercompetition making the best of times shorter?. Strateg Manag J 2005, 26:887-911.
56. Doucette W.R., Nevins J.C., Gaither C., et al. Organizational factors influencing pharmacy practice change. Res Soc Adm Pharm 2012, 8:274-284.
57. Mobach M.P. The merits of a robot: a Dutch experience. J Pharm Pharm Sci 2006, 9:376-387.
58. Ruhle R., Braun R., Ostermann H. Impact of robotic dispensing machines in German pharmacies on business performance indicators. Libyan J Med 2009, 4:146-151.
59. Alston G.L., Blizzard J.C. The value prescription: relative value theorem as a call to action. Res Soc Adm Pharm 2012, 8:338-348.